Cadre Holdings, Inc. SEC filings document the company's safety-equipment business, public-company governance and NYSE-listed common stock. Form 8-K reports cover operating results, financial condition, Regulation FD presentations, material events and related exhibits for its law enforcement, first responder, military and nuclear safety markets.
Cadre's filings also include proxy materials for annual meeting matters, board and stockholder voting procedures, and corporate governance disclosures. Financial-result filings discuss GAAP measures alongside non-GAAP metrics such as EBITDA, adjusted EBITDA and adjusted EBITDA margin, while event reports address material agreements, acquisition-related communications, capital-structure disclosures and security registration details for CDRE common stock.
Cadre Holdings, Inc.'s amended ownership disclosure reports four open-market sales by reporting person Kanders SAF, LLC: 65,431 shares at a weighted average $33.20 and 34,569 at $33.65 on August 24, 2026; then 55,345 at $31.54 and 44,655 at $32.28 on August 25. The respective sale-price ranges were $32.95–$33.50, $33.50–$34.00, $31.26–$31.98 and $32.01–$32.95 per share.
As of September 28, 2026, reporting person Warren B. Kanders reported beneficial ownership of 11,117,928 shares (25.8%), including 348,901 options exercisable or exercisable within 60 days and 23,450 shares in Allison Kanders Roth IRA; he disclaims beneficial ownership of the Roth IRA shares except to the extent of his pecuniary interest. Kanders SAF separately reported 9,417,039 shares (22.0%). A pledge amendment placed 2,000,000 shares in a pledged account as collateral for Kanders' Bank of America loan and provided previously unavailable margin borrowing capacity on those shares. The disclosure also identifies a 3,750,000-share security interest in favor of Texas Capital Bank.
Cadre Holdings, Inc. (CDRE) reported insider transactions by CEO, Chairman and >10% owner Warren B. Kanders. Through Kanders SAF, LLC, he sold 200,000 shares of Common Stock on August 24–25, 2026 in open-market transactions at weighted average prices ranging from $31.54 to $33.65 per share. After these sales, Kanders SAF, LLC held 9,551,608 shares indirectly, while additional positions reported include 22,888 shares held directly, 1,305,650 shares held through a Warren B. Kanders Roth IRA, and 23,450 shares held through an Allison Kanders Roth IRA. The reporting person is the sole manager and member of Kanders SAF, LLC and disclaims beneficial ownership of certain securities except to the extent of his pecuniary interest.
Cadre Holdings, Inc. (CDRE) is the issuer of common stock that Warren B. Kanders has notified for potential sale under Rule 144. The notice lists up to 100,000 shares of common stock to be sold through Merrill Lynch on the NYSE, with an aggregate market value of $3,186,000. The filing cites 42,820,734 shares of Cadre Holdings common stock outstanding and references Kanders’ interest in Kanders SAF, LLC and a prior liquidating distribution from Maui Holdings LLC. Recent Rule 144 disclosure also includes several prior common stock sales by Kanders over the past three months.
Cadre Holdings, Inc. (CDRE) is the issuer of common stock referenced in a Rule 144 notice filed for the account of Warren B. Kanders. The notice indicates an intention to sell 100,000 shares$3,336,00042,820,734December 7, 202115,866,703300,000 shares
Cadre Holdings, Inc. (CDRE) reported that its President, Brad Williams, exercised stock options and sold shares on August 17, 2026. He exercised options covering 88,742 shares of Common Stock at exercise prices of $23.45 and $20.53 per share under the company’s 2021 Stock Incentive Plan. The transactions resulted in the acquisition of 42,770 and 45,972 shares of Common Stock, with 107,851 shares reported as directly owned immediately after one of the exercises. On the same date he sold a total of 88,742 shares of Common Stock in open-market transactions at weighted average prices of $34.34 (range $34.25–$34.38) and $33.24 (range $33.02–$33.66) per share. The filing indicates these trades were not made pursuant to a Rule 10b5-1 trading plan.
Cadre Holdings, Inc. (CDRE) reports a planned sale of common stock under Form 144. The notice covers common shares with an aggregate market value of 3,029,651.88, with 42,820,734 common shares outstanding as context. The proposed transaction date is August 17, 2026 on the NYSE. The shares relate to the exercise of stock options42,770 and 45,972 shares.
Cadre Holdings, Inc. filed an amended report to correct an error in the calculation of its last twelve months adjusted EBITDA in previously released Q2 2026 materials; underlying operating results are unchanged. For the quarter ended June 30, 2026, net sales were $207.1 million, up 32% from $157.1 million a year earlier, and gross profit was $87.1 million, up 36%.
Gross margin improved to 42.1%. Net income was $11.4 million versus $12.2 million, as higher contingent consideration, compensation and foreign exchange impacts offset stronger gross profit. Adjusted EBITDA rose to $42.0 million, with margin expanding to 20.3%. Orders backlog reached a record $368 million. Management raised its 2026 outlook to net sales of $749–$769 million and adjusted EBITDA of $139–$144 million, with expected capital expenditures of $10–$14 million.
For the first half of 2026, operating cash flow increased to $44.7 million, while business acquisitions of $163.9 million contributed to higher total debt and reduced cash and restricted cash to $57.7 million. The company highlighted an FBI-related ballistic armor IDIQ contract opportunity, the Alien Gear Holsters acquisition, and a quarterly dividend of $0.10 per share.
FMR LLC filed an amended Schedule 13G reporting beneficial ownership of 2,475,622.54 shares of Cadre Holdings, Inc. common stock, representing 5.8% of the class. FMR reports sole dispositive power over all of these shares and sole voting power over 2,475,549 shares, with no shared voting or dispositive power.
Abigail P. Johnson is also listed as a reporting person, with sole dispositive power over the same 2,475,622.54 shares. One or more other persons have rights to dividends or sale proceeds from these securities, but no such person holds more than five percent of the outstanding common stock.
Cadre Holdings, Inc. has filed Amendment No. 1 to a Form S-4 acquisition shelf registration covering 7,500,000 shares of common stock, par value $0.0001 per share. These shares may be issued from time to time as stock consideration in negotiated acquisitions of assets, businesses or securities, potentially alongside cash, notes, assumption of liabilities or other consideration. Cadre states it does not expect to receive cash proceeds from this offering other than the value of acquired assets or businesses. The common stock is listed on the NYSE under symbol CDRE, and the last reported price was $30.83 per share on July 31, 2026. As context, Cadre is authorized to issue 190,000,000 shares of common stock and 10,000,000 shares of preferred stock, with 42,797,451 common shares outstanding as of July 31, 2026, and currently pays a $0.10 quarterly dividend ($0.40 annualized). The amendment primarily updates the prospectus, filing fee table, and auditor consent while preserving Cadre’s flexibility to use equity as acquisition currency.